|
DDI2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.19710000029616E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.49050000119999E-08 |
| Normal-vs-Stage2 |
1.976670E-03 |
| Normal-vs-Stage3 |
1.66117999998994E-05 |
| Normal-vs-Stage4 |
2.10739999999543E-05 |
| Stage1-vs-Stage2 |
5.041600E-01 |
| Stage1-vs-Stage3 |
7.533200E-01 |
| Stage1-vs-Stage4 |
3.445200E-01 |
| Stage2-vs-Stage3 |
7.520200E-01 |
| Stage2-vs-Stage4 |
1.792180E-01 |
| Stage3-vs-Stage4 |
2.089600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.62849999941051E-09 |
| Normal-vs-AfricanAmerican |
1.10800000285849E-08 |
| Normal-vs-Asian |
1.943280E-03 |
| Caucasian-vs-AfricanAmerican |
3.975400E-01 |
| Caucasian-vs-Asian |
5.715400E-01 |
| AfricanAmerican-vs-Asian |
7.747400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.49276163547074E-12 |
| Normal-vs-Female |
5.843700E-02 |
| Male-vs-Female |
2.289800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.6028999999942E-05 |
| Normal-vs-Extreme_Weight |
1.63857816204427E-12 |
| Normal-vs-Obese |
4.65599999999178E-06 |
| Normal-vs-Extreme_Obese |
2.009000E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.794200E-02 |
| Normal_Weight-vs-Obese |
7.570200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.985800E-01 |
| Extreme_Weight-vs-Obese |
8.020400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.912400E-01 |
| Obese-vs-Extreme_Obese |
3.983000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.758100E-04 |
| Normal-vs-Age(41-60Yrs) |
8.13630000040533E-08 |
| Normal-vs-Age(61-80Yrs) |
3.52189999386354E-09 |
| Normal-vs-Age(81-100Yrs) |
3.87670000000506E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.432800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.110800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.111400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.170400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.423400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.159200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.46833672892899E-12 |
| Normal-VS-Type2 PRCC |
9.84929999999773E-05 |
| Normal-VS-KIRP CIMP |
1.180460E-02 |
| Normal-VS-Unclassified PRCC |
2.001400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.378300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.692440E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.948300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.010400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.324000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.359400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.5258000002637E-07 |
| Normal-vs-N1 |
4.96120000004208E-06 |
| Normal-vs-N2 |
8.320600E-03 |
| N0-vs-N1 |
9.204000E-01 |
| N0-vs-N2 |
7.622200E-01 |
| N1-vs-N2 |
6.966400E-01 |
|
|
